KA
Kristen Ambrose
SVP & Chief Accounting Officer

Kristen Ambrose insider trades: Vertex Pharmaceuticals Inc / Ma (VRTX) stock sales

SVP & Chief Accounting Officer, Vertex Pharmaceuticals Inc / Ma Last trade Feb 26, 2026 23 Form 4 filings
$2.0M
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2022
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kristen reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 26, 2026VRTX↓ Sell$173K
Feb 25, 2026VRTX↓ Sell$108K
Feb 18, 2026VRTX↓ Sell$1.1M
Feb 11, 2026VRTX↓ Sell$634K
Feb 25, 2025VRTX↓ Sell$425K
Feb 18, 2025VRTX↓ Sell$305K
Feb 11, 2025VRTX↓ Sell$633K
Apr 2, 2024VRTX↓ Sell$101K
Feb 26, 2024VRTX↓ Sell$376K
Feb 12, 2024VRTX↓ Sell$577K
May 30, 2023VRTX↓ Sell$95K
Feb 27, 2023VRTX↓ Sell$347K
Apr 25, 2022VRTX↓ Sell$88K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other VRTX insiders

Open-market trades in the last 12 months

About Kristen Ambrose's insider trades

Kristen Ambrose is SVP & Chief Accounting Officer at Vertex Pharmaceuticals Inc / Ma (VRTX). Since Apr 25, 2022, Kristen has reported no open-market purchases and 13 sales worth $4.9M on SEC Form 4. In the last 12 months: 4 sales ($2.0M).

Their filings also include shares withheld for taxes (14 filings), grants and awards (7 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.